Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19
Farzaneh Dastan, Ali Saffaei, Seyed Mehdi Mortazavi, Hamidreza Jamaati, Nadia Adnani, Sasan Samiee Roudi, Arda Kiani, Atefeh Abedini, Seyed Mohammad Reza Hashemian
Abstract
Cytokine release syndrome is prevalent in severe cases of COVID-19. In this syndrome, an uncontrolled response of immune system occurs. Extracorporeal blood purification has been proven to effectively remove the released inflammatory cytokines. Here, we reported a successful case to represent our experience of extracorporeal blood purification in a patient with severe COVID-19.
Topics & Concepts
HemoperfusionExtracorporealMedicineCoronavirus disease 2019 (COVID-19)Renal replacement therapyIntensive care medicine2019-20 coronavirus outbreakExtracorporeal membrane oxygenationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)SurgeryHemodialysisInternal medicineVirologyDiseaseInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19